Martin Ruttledge

2.2k total citations
27 papers, 1.6k citations indexed

About

Martin Ruttledge is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Martin Ruttledge has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 8 papers in Pathology and Forensic Medicine and 8 papers in Epidemiology. Recurrent topics in Martin Ruttledge's work include Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Migraine and Headache Studies (6 papers). Martin Ruttledge is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Migraine and Headache Studies (6 papers). Martin Ruttledge collaborates with scholars based in Sweden, Canada and United States. Martin Ruttledge's co-authors include Jan P. Dumanski, Guy A. Rouleau, Magnus Nordenskjöld, V. Peter Collins, Catherine M. Phelan, Olivier Delattre, Gilles Thomas, P. Merel, Fei‐Yu Han and Ya‐Gang Xie and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Ruttledge

26 papers receiving 1.6k citations

Peers

Countries citing papers authored by Martin Ruttledge

Since Specialization

Citations

This map shows the geographic impact of Martin Ruttledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ruttledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ruttledge more than expected).

Fields of papers citing papers by Martin Ruttledge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Ruttledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ruttledge. The network helps show where Martin Ruttledge may publish in the future.

Co-authorship network of co-authors of Martin Ruttledge

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Ruttledge. A scholar is included among the top collaborators of Martin Ruttledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Ruttledge. Martin Ruttledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17–30 months	The Journal of Headache and Pain	Alina Buture, Róisín Lonergan et al.	11
2	Inflammatory complications of CGRP monoclonal antibodies: a case series	The Journal of Headache and Pain	Jason C. Ray, Penelope J. Allen et al.	40
3	Migraine and Headache Care in the Republic of Ireland: History and a Vision for the Future Influenced by the COVID‐19 Pandemic	Headache The Journal of Head and Face Pain	Audrey Craven, Martin Ruttledge et al.	1
4	Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment	Neurology	Alexander Nesbitt, Juana Marin et al.	111
5	Role of the neurofibromatosis Type 2 gene in the development of tumors of the nervous system	Neurosurgical FOCUS	Martin Ruttledge, Guy A. Rouleau	7
6	Cystic fibrosis mutation frequencies in an Irish population	Clinical Genetics	James Devaney, M. Glennon et al.	15
7	The Human Mammary-Derived Growth Inhibitor (MDGI) Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors	Genomics	Catherine M. Phelan, Catharina Larsson et al.	29
8	Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus	Nature Genetics	Catherine M. Phelan, Barbara Weber et al.	155
9	A point mutation associated with a severe phenotype of neurofibromatosis 2	Annals of Neurology	Mia MacCollin, Kevin Davis et al.	10
10	The Human Mammary-Derived Growth Inhibitor (MDGI) Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors	Genomics	Catherine M. Phelan, Catharina Larsson et al.	0
11	Characterization of a new member of the human /-adaptin gene family from chromosome 22q12, a candidate meningioma gene	Human Molecular Genetics	Myriam Peyrard, Ingegerd Fransson et al.	81
12	Physical Mapping of the NF2/Meningioma Region on Human Chromosome 22q12	Genomics	Martin Ruttledge, Ya‐Gang Xie et al.	11
13	Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression	International Journal of Cancer	Annika Lindblom, Martin Ruttledge et al.	79
14	The neurofibromatosis type 2 gene is inactivated in schwannomas	Human Molecular Genetics	Martin Ruttledge, Marylène Rousseau et al.	118
15	Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas	Nature Genetics	Martin Ruttledge, Catherine M. Phelan et al.	433
16	Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus	Human Molecular Genetics	Marc Sanson, Claude Marineau et al.	47
17	Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12	Human Molecular Genetics	Fei‐Yu Han, Martin Ruttledge et al.	22
18	Neurofibromatosis type 2 appears to be a genetically homogeneous disease.	Europe PMC (PubMed Central)	Steven A. Narod, Dilys M. Parry et al.	41
19	Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter	Human Genetics	Jan P. Dumanski, A.H.M. Geurts van Kessel et al.	18
20	Rapid minipreparations of bacteriophage DNA	Nucleic Acids Research	Jan P. Dumanski, Martin Ruttledge et al.	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact